Bharat Rakshak

IndraD wrote:not that easy to explain
place i come from is deep in Hindi heartland. People are moving around doing businesses without mask or precautions and still not many cases, not many deaths or serious hospitalisation either with respiratory failure. there are multiple factors at play

Primus wrote:

mappunni wrote: Got the newer Shingles vaccine today and my Primary care physician said it is very effective. In Texas, they have different sets of guidelines on who gets the Chinese virus vaccine. I was told being diabetic, I should be able to get one of the Chinese virus vaccines in the next couple of weeks.

Please make sure you wait at least four-six weeks between the Shingles shot and the COVID vaccine, you don't want to confuse your immune system. Plus the Shingles IIRC is a live virus vaccine so you don't want to mix up two virus particles in your system.

Britain Opts for Mix-and-Match Vaccinations, Confounding Experts
If a second dose of one vaccine isn’t available, another may be substituted, according to new U.K. guidelines.

“This option is preferred if the individual is likely to be at immediate high risk or is considered unlikely to attend again,” the recommendation said. Because both vaccines target the spike protein of the coronavirus, “it is likely the second dose will help to boost the response to the first dose.”

Following requests for comment, officials at Public Health England drew attention to the similarities between the Pfizer and AstraZeneca vaccines, and said that clinical trials testing mixed regimens were to start sometime this year.

While it’s possible that swapping out one vaccine for another may still school the body to recognize the coronavirus, it is still a scientific gamble. With different ingredients in each vaccine, it’s possible people will not benefit as much from a second shot. Mixing and matching could also make it more difficult to collect clear data on vaccine safety.

Without evidence to back it, the hybrid vaccination approach seems “premature,” said Saad Omer, a vaccine expert at Yale University. Still, it’s not without precedent: Health authorities like the C.D.C. have previously said that if it’s impossible to give doses of a vaccine from the same manufacturer, “providers should administer the vaccine that they have available” to complete an injection schedule.

In a controversial move, the British government this week also decided to frontload its vaccine rollout, delivering as many first doses to people as possible — a move that could delay second shots up to 12 weeks.

The speedy deployment might afford more people partial protection against the virus in the short term. But some experts, including Dr. Moore, worry that this, too, might be unwise, and could imperil vulnerable populations.

A vaccination gap that stretches on too long may hamstring the second shot’s ability to boost the protective powers of the first — or raise the odds that people will forget, or decide against, returning for another injection.

In 1st phase of #COVID19Vaccination free #vaccine shall be provided across the nation to most prioritised beneficiaries that incl 1 crore healthcare & 2 crore frontline workers
Details of how further 27 cr priority beneficiaries are to be vaccinated until July are being finalised

Zynda wrote:Dr Harsh Vardhan
@drharshvardhan

In 1st phase of #COVID19Vaccination free #vaccine shall be provided across the nation to most prioritised beneficiaries that incl 1 crore healthcare & 2 crore frontline workers
Details of how further 27 cr priority beneficiaries are to be vaccinated until July are being finalised

Which means that majority of the Indians will start receiving vaccine only after July...so another 8-9 months of constant wearing masks plus hand washing?

IndraD wrote:Inactivated virus vaccine Covaxin from Bharat Biotech approved for emergency usage in India.

IndraD wrote:Oxford university has 6% stake on every vaccine sold in the world. This will give some cash to cash starved university. on BBC their chairman told Oxford gave penicillin to the world in 1940 but regret to have not made any money out of it, cos we need money for new research.

chola wrote: So unless something unforeseen happens, Indians should hold steady and by the time the vaccines arrive we might be able to completely annihilate the virus from India.

We were close to 1 lakh cases a day in September. On Jan 1st, we had just 17K.

India has not just flattened the curve but CRUSHED it. The trendline is on a rapid downward slope!

Zynda wrote:Dr Harsh Vardhan
@drharshvardhan

In 1st phase of #COVID19Vaccination free #vaccine shall be provided across the nation to most prioritised beneficiaries that incl 1 crore healthcare & 2 crore frontline workers
Details of how further 27 cr priority beneficiaries are to be vaccinated until July are being finalised

Which means that majority of the Indians will start receiving vaccine only after July...so another 8-9 months of constant wearing masks plus hand washing?

abhishekm wrote:Aren't vaccines going to be made privately available although at a higher cost? I think we can walk in to any private hospital and pay 4X or whatever and get the jab. No need to wait until August.

Anyone who can pay should get it done this way to reduce the strain on GoI's effort...

vijayk wrote:
new game in the town

Zynda wrote:

abhishekm wrote:Aren't vaccines going to be made privately available although at a higher cost? I think we can walk in to any private hospital and pay 4X or whatever and get the jab. No need to wait until August.

Anyone who can pay should get it done this way to reduce the strain on GoI's effort...

I think until there are sufficient stocks of vaccine vials/doses, availability will be regulated...

Also, India is recommending two doses of shots 30 days apart for both Oxford as well as Covaxin shots.

The Serum Institute of India Ltd., which is producing the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford, expects the Indian government to sign a formal supply and pricing agreement within days.

Officials in New Delhi have informally agreed that the first 100 million vaccines will be purchased and priced at 200 rupees ($2.74), Serum’s Chief Executive Officer Adar Poonawalla said in an interview on Sunday. The vaccine will cost 1,000 rupees on the private market, which may be approved “in two or three months," he said.